In a deal that will allow both companies to focus more on their prescription drug business, Pfizer and GlaxoSmithKline plan to combine their over-the-counter (OTC) consumer healthcare units; 2 antiabortion groups want National Institutes of Health (NIH) National Director Francis Collins, MD, to resign after he defended the agency’s funding of fetal tissue research; despite the fact that 20 veterans die a day from suicide, suicide prevention efforts at the Department of Veterans Affairs (VA) have slumped.
In a deal that will allow both companies to focus more on their prescription drug business, Pfizer and GlaxoSmithKline plan to combine their consumer healthcare units and eventually spin off the joint venture, The Wall Street Journal reported. The venture will become the world's largest seller of over-the-counter (OTC) medicines.
Two antiabortion groups, March for Life and Live Action, want National Institutes of Health (NIH) National Director Francis Collins, MD, to resign after he defended the agency’s funding of fetal tissue research. The Hill reported that he told Science magazine that fetal tissue would “continue to be the mainstay” for research. HHS is conducting a review of more than $100 million in federal funding of these projects and is expected to reach a decision in the coming months. It did cancel a contract with 1 fetal tissue firm after facing pressure from the antiabortion groups.
Despite the fact that 20 veterans die a day from suicide, suicide prevention efforts at the Department of Veterans Affairs (VA) have slumped, according to a Government Accountability Office report. The report blamed bureaucratic confusion and key vacancies, The New York Times said. The VA spent just $57,000 of its $6.2 million media budget, and its presence on social media, mostly paid posts, declined by 77% from the levels of 2015. In a response, the VA agreed with the assessment and said that it was already working on correcting the problems.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More